Match Document Document Title
7618961 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1  
The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the...
7615569 Inhibitors of ion channels  
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly,...
7612052 Combinations comprising epothilones and pharmaceutical uses thereof  
The invention relates to a combination which comprises (a) a bisphosphonate, a platinum compound or a vasculostatic compound and (b) an epothilone derivative of formula I wherein A represents O...
7605269 Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists  
The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.
7605172 Thiazolo-naphthyl acids  
The present invention relates to thiazolo-naphthyl acids of the formula and methods of using them to modulate PAI-1 expression and to treat PAI-1 related disorders.
7605156 Methods for the use of inhibitors of cytosolic phospholipase A2  
This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the...
7598280 Heterocyclic compounds, compositions comprising them and methods of their use  
Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed....
7598245 Aminotriazole compounds useful as inhibitors of protein kinases  
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the...
7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors  
The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R 1 and R 8 each are...
7595318 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids  
Disclosed are conjugates which bind VLA-4. Certain of these conjugates also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such conjugates are useful in the...
7592361 Indole acetic acid derivatives and their use as pharmaceutical agents  
This invention is directed to indole acetic acid derivatives and their use in pharmaceutical compositions for the treatment of diseases such as diabetes, obesity, hyperlipidemia, and...
7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5  
Tetrazole compounds substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring,...
7585880 Phenylpropanoic acid derivatives  
The present invention provides a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, a drug for the prophylaxis or treatment of diabetes...
7582664 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics  
The invention relates to a compound of formula (I): Wherein R 1 , R 2 , R 2′ , R 3 , R 4 and R 5 are as defined herein. The invention also relates to the use of said compound in therapeutics.
7579477 Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof  
Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of...
7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders  
The present invention is directed to compounds having the structure wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined herein. The compounds of this invention are novel therapeutic agents...
7572790 Biphenyl carboxylic amide p38 kinase inhibitors  
Compound of formula (I): or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
7569688 Propane-1, 3-dione derivative  
Provided is a pharmaceutical composition containing a propane-1,3-dione derivative as the active ingredient, particularly a GnRH receptor antagonist. Also, provided is a propane-1,3-dione...
7563901 Intermediates of 2-substituted carbapenem derivatives and process for production thereof  
The present invention relates to compounds represented by formula (1) and a process for producing the same. The use of these compounds can realize the production of carbapenem derivatives having...
7563813 Iminothiazolidinone derivatives as SFRP-1 antagonists  
Compounds of Formula 1, or pharmaceutically acceptable salts thereof, are provided: which are inhibitors of secreted frizzled related protein-1. The compounds, and compositions containing the...
7560568 Thiazole compounds  
The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their...
7560483 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof  
The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require...
7560475 Phenylacetic acid derivative, process for producing the same, and use  
The present invention relates to the compound represented by formula (I) (wherein R 1 and R 2 is hydrogen atom, C1-8 alkyl etc.; R 3 is C1-8 alkyl which may be substituted with 1 to 3...
7557095 Therapeutic compounds  
Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are...
7553859 Macrocycles for the treatment of cancer  
The present invention relates to new Macro-cycles of Formula (I), and their use for the treatment of cancer.
7550491 Ionic liquids having [N(CF3)2]anions  
The present invention relates to salts comprising bis(trifluoromethyl)imide anions and saturated, partially or fully unsaturated, heterocyclic cations, to a process for the preparation thereof, and...
7550448 Therapeutic compounds  
Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also...
7547701 Haloalkyl containing compounds as cysteine protease inhibitors  
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these...
7541354 Bicyclo-pyrazoles  
Bicyclo-pyrazole compounds of formula (I), as herein defined, are useful for treating diseases linked to disregulated protein kinases.
7538128 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them  
The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R 1 , and R 2 are as defined herein.
7531563 Thiazoline acid derivatives  
The present invention relates to novel thiazoline acids and derivatives thereof useful as chelators of trivalent metals in therapeutic applications. For example, the thiazoline acid derivatives are...
7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy  
Compositions, pharmaceutical preparations and methods are disclosed for protecting non-neoplastic cells from damage caused by cancer chemotherapeutic agents or radiation therapy, during the course...
7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles  
Bicyclo-pyrazole compounds of formula (I), as herein defined, are useful for treating diseases linked to disregulated protein kinases.
7528160 Fused heterocyclic derivatives as PPAR modulators  
The present invention is directed to a method of treatment by modulating a peroxisome proliferator activated receptor by employing a compound of Structural Formula (I). The variables in I are...
7524957 Compounds effecting glucokinase  
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R 1 , R 2 , R 3 , n and m are as described in the specification, in the preparation of a...
7524876 Luciferin derivatives  
A compound represented by the following general formula (I) or a salt thereof: [wherein R 1 and R 2 represent hydrogen atom, a C 1-6 alkyl group, or a group represented by the following...
7524870 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators  
The present invention relates to compounds of formula (I) wherein Ar, Ar 2 , R 2 , R 3 , R 4 , m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts...
7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient  
A compound which inhibits the production of IL-6 and/or TNFα by inflammatory cytokines and is useful in the prevention of or treatments for diseases such as various inflammatory diseases in which...
7521461 Benzoic acid derivatives as modulators of PPAR alpha and gamma  
A compound of formula (I) wherein R 1 represents aryl optionally substituted by a heterocyclic group or a heterocyclic group optionally substituted by aryl wherein each aryl or heterocyclic group...
7517535 Non-systemic control of parasites  
Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
7511034 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses  
Novel dialkylhydroxybenzoic acid derivatives containing metal chelating groups are disclosed. The novel compounds are used as therapeutics for treating and/or preventing various medical...
7504513 Thiazolyl-benzimidazoles  
The invention is directed to compounds of formula (1) and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.
7504431 Sulfonyl amide inhibitors of calcium channel function  
Compounds of formula I its stereoisomers, solvates, and salts, thereof, wherein: a, b, c, d, f, n, m and Ra are defined herein are are inhibitors of calcium channel function, and are useful in...
7504423 α-amino acid derivatives and use thereof as medicines  
Compounds represented by the α-amino acid derivative or a pharmaceutically acceptable salt thereof of the present invention have a therapeutic effect due to a DPP-IV inhibitory action and useful...
7504420 Compounds which inhibit beta-secretase activity and methods of use  
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease.
7504402 Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1  
Triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as...
7476742 Indane acetic acid derivatives and their use as pharmaceutical agents  
This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases and to...
7468360 Therapeutic amides and related compounds  
Disclosed herein is a compound having a structure: Therapeutic methods, compositions, and medicaments relating thereto are also disclosed.
7462635 Thiazole and oxazole VDAC regulator  
The present invention provides a VDAC regulator comprising a compound represented by the formula (I): wherein R 1 is a halogen atom, an optionally substituted heterocyclic group, an optionally...
7459473 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres  
This invention relates to novel N-linked sulfonamides of N-heterocyclic carboxylic acid and carboxylic acid isosteres, their preparation, and use for treating neurological disorders including...